These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 4010160)
21. Electrophoretic patterns of serum protein and lipoprotein of nephrotic children. Roy Chowdhury DK J Indian Med Assoc; 1983 Aug; 81(3-4):41-5. PubMed ID: 6655267 [No Abstract] [Full Text] [Related]
22. Plasma lipoprotein lipase in children with idiopathic nephrotic syndrome. Hyman LR; Wong PW; Grossman A Pediatrics; 1969 Dec; 44(6):1021-4. PubMed ID: 5365049 [No Abstract] [Full Text] [Related]
23. Relationship among the concentrations of serum lipoproteins and changes in their chemical composition in patients with untreated nephrotic syndrome. Gherardi E; Rota E; Calandra S; Genova R; Tamborino A Eur J Clin Invest; 1977 Dec; 7(6):563-70. PubMed ID: 415877 [No Abstract] [Full Text] [Related]
24. Study of serum lipid pattern in nephrotic syndrome in children. Katiyar GP; Singh CK; Agarwal KN; Singh RH Indian Pediatr; 1976 Feb; 13(2):83-8. PubMed ID: 1278965 [No Abstract] [Full Text] [Related]
25. Lipid abnormalities in the nephrotic syndrome: the therapeutic role of statins. Wheeler DC J Nephrol; 2001; 14 Suppl 4():S70-5. PubMed ID: 11798150 [TBL] [Abstract][Full Text] [Related]
29. Comprehensive study on platelet function, hemostasis, fibrinolysis, peripheral serotonergic system and serum lipids in nephrotic syndrome. Małyszko J; Małyszko JS; Pawlak D; Pawlak K; Rydzewski A; Myśliwiec M; Buczko W Pol J Pharmacol; 1996; 48(2):191-5. PubMed ID: 9112650 [TBL] [Abstract][Full Text] [Related]
30. [The clearing factor and the inhibiting factor during lipoid nephrosis]. LARCAN A; WOLFF J; WOLFF R J Urol Nephrol (Paris); 1961 Jun; 67():425-32. PubMed ID: 14462392 [No Abstract] [Full Text] [Related]
31. [On the lipid and fatty acid composition of the blood serum in subjects with glomerulonephrits with the nephrotic syndrome]. Pisano L; Lombardi D; Spanò G Boll Soc Ital Cardiol; 1967; 12(1):27-36. PubMed ID: 5596746 [No Abstract] [Full Text] [Related]
32. [Lipid metabolic disorders and lipid peroxidation in patients with the nephrotic syndrome]. Shishkin AN; Kolmakova EV; Ashirova KV Urol Nefrol (Mosk); 1994; (3):39-41. PubMed ID: 8079411 [TBL] [Abstract][Full Text] [Related]
33. [Blood lipids, electrophoretic proteinogram, lipoproteinogram and glycoproteinogram in the development of nephrotic syndrome in children]. RAMON-GUERRA AU; KORC I; BAUZA CA Arch Pediatr Urug; 1959 Jun; 30():342-64. PubMed ID: 14436071 [No Abstract] [Full Text] [Related]
34. [Changes in serum lipoproteins in kidney diseases]. Mordasini R; Riesen W Schweiz Med Wochenschr; 1982 Sep; 112(39):1335-40. PubMed ID: 6755693 [TBL] [Abstract][Full Text] [Related]
35. Studies on the metabolism of plasma proteins in the nephrotic syndrome. II. The lipoproteins. GITLIN D; CORNWELL DG; NAKASATO D; ONCLEY JL; HUGHES WL; JANEWAY CA J Clin Invest; 1958 Feb; 37(2):172-84. PubMed ID: 13513748 [No Abstract] [Full Text] [Related]
37. [Lipoproteins, apolipoproteins, lipoprotein lipase, hepatic triglyceride lipase and lecithin cholesterol acyltransferase in patients with nephrotic syndrome]. Breier C; Lisch HJ; Drexel H; Braunsteiner H Schweiz Med Wochenschr; 1983 Jun; 113(25):909-13. PubMed ID: 6612272 [TBL] [Abstract][Full Text] [Related]
38. [Effect of Trascolan on protein-lipid content of serum in patients with nephrotic syndrome]. Markiewicz K; Walasek L; Lutz W Pol Tyg Lek; 1972 Feb; 27(8):308-11. PubMed ID: 4536812 [No Abstract] [Full Text] [Related]